Shen Ze-Feng, Liang Xiao
Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 310016, Zhejiang Province, China.
World J Clin Cases. 2021 Apr 16;9(11):2419-2432. doi: 10.12998/wjcc.v9.i11.2419.
The laparoscopic technique is clinically effective in treating hepatocellular carcinoma (HCC) with portal hypertension (PHT). However, existing studies lack systematic arrangement and induction. Here, we review the latest research advancement in laparoscopic technique for treatment of HCC with PHT, based on published literature and our single-institution experience. Our single-center experience reveals no statistical difference in both short- and long-term prognosis of HCC patients after laparoscopic liver resection (LLR), regardless of whether they suffer from PHT, which is consistent with previous studies on the use of LLR for HCC with PHT. Retrieval outcomes indicate existence of short- and long-term prognostic superiority, following laparoscopic treatment, relative to non-laparoscopic treatment. Besides that, LLR offers long-term prognostic advantage compared to laparoscopic radiofrequency ablation. In addition, we review the previous literature and propose corresponding perspectives on the therapy of hypersplenism, the utilization of Pringle maneuver, and the adoption of anatomical hepatectomy during radical laparoscopic treatment. HCC with PHT is not the "forbidden zone" of radical laparoscopic treatment. However, patients' preoperative liver function should be adequately estimated.
腹腔镜技术在治疗伴有门静脉高压(PHT)的肝细胞癌(HCC)方面具有临床疗效。然而,现有研究缺乏系统的整理和归纳。在此,我们基于已发表的文献和我们单机构的经验,综述腹腔镜技术治疗伴有PHT的HCC的最新研究进展。我们单中心的经验表明,腹腔镜肝切除术(LLR)后,HCC患者无论是否患有PHT,其短期和长期预后均无统计学差异,这与先前关于LLR治疗伴有PHT的HCC的研究结果一致。检索结果表明,与非腹腔镜治疗相比,腹腔镜治疗在短期和长期预后方面具有优势。除此之外,与腹腔镜射频消融相比,LLR具有长期预后优势。此外,我们回顾了既往文献,并对根治性腹腔镜治疗期间脾功能亢进的治疗、Pringle手法的应用以及解剖性肝切除术的采用提出了相应的观点。伴有PHT的HCC并非根治性腹腔镜治疗的“禁区”。然而,应充分评估患者术前的肝功能。